Financhill
Back

United Therapeutics Stock Predictions

United Therapeutics Stock Forecast

  • Over the next 52 weeks, United Therapeutics has on average historically risen by 30.7% based on the past 26 years of stock performance.
  • United Therapeutics has risen higher in 19 of those 26 years over the subsequent 52-week period, corresponding to a historical accuracy of 73.08%
  • Is United Therapeutics Stock Undervalued?
    The current United Therapeutics [UTHR] share price is $309.22. The Score for UTHR is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • UTHR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will United Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, United Therapeutics has on average historically risen by 30.7% based on the past 26 years of stock performance.

United Therapeutics Stock Rating

Sell
49
United Therapeutics (UTHR) is a Sell

Is United Therapeutics overpriced?

  • United Therapeutics has risen higher in 19 of those 26 years over the subsequent 52-week period, corresponding to a historical accuracy of 73.08%

United Therapeutics Stock Price History

Is UTHR stock going to rise?

  • The current trend is moderately bullish and UTHR is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
unither.com

52-Week Data

52-Week High:
417.82
52-Week Low:
266.98

Prediction Charts

Market Cap:
14B
Price in USD:
309.22
Volume:
1.3M
Beta:
0.52

Technical Analysis

SMA50:
297.58
SMA100:
299.13
SMA200:
326.59
52-Wk Change:
-10.8%

Stock Predictions

  • Is United Therapeutics stock public?
    Yes, United Therapeutics is a publicly traded company.
  • What is the United Therapeutics stock quote today?
    The United Therapeutics stock price is 309.22 USD today.
  • How to buy United Therapeutics stock online?
    You can buy United Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Aug-7 302.22 299.42 304.77 296.57
Aug-8 297.38 301.50 305.36 297.38
Aug-11 301.97 300.43 306.00 300.24
Aug-12 298.76 301.39 302.68 292.34
Aug-13 302.96 309.72 310.07 301.30
Aug-14 308.83 312.06 312.48 305.00
Aug-15 312.13 313.13 314.24 310.61
Aug-18 314.03 314.10 316.21 311.55
Aug-19 314.10 313.22 317.31 311.36
Aug-20 313.22 306.48 314.98 306.01
Aug-21 303.59 310.66 311.37 303.59
Aug-22 310.00 312.23 315.73 308.26
Aug-25 310.72 305.38 312.65 304.84
Aug-26 306.76 309.22 309.34 304.48

United Therapeutics Earnings

United Therapeutics Earnings Report: Per Share United Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

United Therapeutics Forecast Revenue Growth

United Therapeutics Stock Analysis: Historical quarterly revenues per share for United Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.68 per share, an increase next quarter of $0.84 per share, an increase this year of $1.86 per share, and an increase next year of $1.85 per share.

* United Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.